This editorial reflects on two decades of translational geroscience research, examining how mechanistic aging studies have advanced clinical applications and longevity interventions. The work underscores the field's evolution from understanding why we age toward implementing evidence-based strategies that modify aging trajectories in human populations.
Key Points
- Translational geroscience bridges aging mechanisms to clinical practice.
- Twenty years of research now enables targeted interventions on aging.
- Human trials demonstrate feasibility of age-related disease prevention.
Longevity Analysis
The progression from mechanistic understanding to clinical application represents a fundamental shift in how aging can be addressed. Rather than accepting age-related decline as inevitable, this body of work demonstrates that identifying the specific processes driving dysfunction—whether in energy production, regeneration, stress response, or hormonal signaling—creates the foundation for meaningful intervention. The field has moved beyond theoretical knowledge to demonstrating that intentional, sustained protocols can measurably alter aging outcomes in humans, establishing geroscience as a clinically relevant discipline rather than an exploratory science.
Original published by Wiley Aging Cell, by Monty Montano .